Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
Clinical trial NCT01998828 · TERMINATED
Trial details
- NCT number
- NCT01998828
- Sponsor
- Sierra Oncology LLC - a GSK company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-19
- Primary completion
- 2015-03-17
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.